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ABSTRACT 
 
BACKGROUND: nocardiosis is an opportunistic infectious disease 
in immunocompromised patients. The most common form of 
nocardiosis infection in humans is pulmonary nocrdiosis caused by 
inhaling Nocardia species from the environment. Thus, this study 
aimed to evaluate the pulmonary nocardiosis in patients with 
suspected tuberculosis using systematic review and meta-analysis. 
METHODS: We conducted a systematic search for cross-sectional 
studies focused on the pulmonary nocardiosis among patients with 
pulmonary tuberculosis based on the Preferred Reporting Items for 
Systematic reviews and Meta-analysis (PRISMA) published from 
January 2001 to October 2019. The search was conducted in 
MEDLINE/PubMed, Web of Science, Scopus, Cochrane Library, 
Google Scholar, Science Direct databases, and Iranian databases. 
Medical subject headings (MeSH) and text words were searched: 
“pulmonary nocardiosis”, “nocardiosis”, OR “nocardial 
infection”, “pulmonary nocardial infections/agents”, AND 
“pulmonary tuberculosis”, OR “pulmonary TB”, AND “Iran”. 
Two of the reviewers enrolled independently articles published in 
English and Persian languages according to the inclusion and the 
exclusion criteria. Comprehensive Meta-Analysis software (Version 
3.3.070) was used for meta-analysis.  
RESULTS: Only 4 studies met the eligibility criteria. The 
pulmonary nocardiosis prevalence varied from 1.7% to 6.7%. The 
combined prevalence of nocardiosis among patients with suspected 
pulmonary tuberculosis in Iran was 4.8% (95% CI: 3-7.3, Q=5.8, 
Z=12.7).  No heterogeneity was observed between studies because 
I2 was 48.3. N. cyriacigeorgica and N. asteroides were reported as 
the prevalent isolates, respectively. 
CONCLUSIONS: This review showed in patients suspected TB 
when they were negative in all diagnosis laboratory tests, 
nocardiosis cases which be considered.   
KEYWORDS: Nocardia infection, nocardiosis, Pulmonary 
Tuberculosis, Pulmonary Nocardioses 
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INTRODUCTION  
 
Nocardiosis is an opportunistic infectious disease 
in immunocompromised individuals and in people 
with healthy immune systems is reported as a case 
(1-4). The nocardiosis spectrum consists of 
pulmonary, cutaneous, subcutaneous, cerebral, 
cutaneous lymphatic or systematic diseases (3-5). 
The most common form of nocardiosis infection in 
humans is a pulmonary form caused by inhaling 
Nocardia species from the environment. So far, 
more than 50 species of Nocardia have been 
identified. Of which, the important pathogenic 
species include N. brasiliensis, N. asteroids 
complex, N. pseudobrasiliensis, N. transvalensis, 
and N. otitidiscaviarum (6). Nocardia is a Gram-
positive, obligatory aerobic, catalase-positive, non-
motility, and relative acid-fast microorganism. It is 
slow-growing and in the culture and tissue 
environment often forms filaments that convert 
easily to coccus and bacillus forms (7). The main 
site of Nocardia species is soil, but it is also found 
in water, sewage and organic residues of plants (8). 
However, the geographic prevalence of each 
species may change tremendously over the world, 
and some are rare (9). These opportunistic bacteria 
are facultative intracellular, which with suppressing 
the immune system, are capable of replacing in 
different parts of the body including the lungs (10). 
Also, they tend to expand to blood circulation and 
cause brain abscesses and skin infections; if they 
are miss-diagnosed and unless timely treated will 
be fatal (11). Since patients with immune-
deficiency, Hematological malignancies, organ 
transplant recipients, AIDS, prolonged 
consumption of corticosteroids, chronic alcoholism 
and diabetes that are deficient in T-cells,  are 
susceptible to pulmonary nocardiosis (12). Some 
patients with nocardiosis usually have a chronic 
underlying pulmonary disease and often under 
Long-term treatment with high doses of 
corticosteroids (13). Clinical signs and radiological 
features of pulmonary nocardiosis are similar to 
that of pulmonary tuberculosis, but its progress is 
faster than tuberculosis having a period of several 
months (14,15). Pulmonary lesions caused by 
pulmonary nocardiosis are predominantly local and 
have no clinical symptoms, and are associated with 
abscess and sometimes pneumonia (16-18). 
Nocardiosis has a worldwide distribution and 
affects predominantly people of between 20 and 60 
years of age (19). The prevalence of the disease in 
Iran is not known and often has been reported as a 
case report. In the USA, the annual incidence rate 
of the disease was reported between 500-1000 
cases (16). In most cases, Nocardia infections are 
not diagnosed quickly because of a lack of specific 
clinical symptoms (20,21).  
Since these organisms are slow to grow, the 
rapid and accurate diagnosis of them from other 
organisms for the treatment of severe infections 
and as well as prevention of brain abscess 
formation is essential. The use of molecular 
methods compared to culture have the high speed, 
accuracy, sensitivity, and specificity in the 
identification of Nocardia species(22). There is the 
lack of comprehensive data on the prevalence of 
pulmonary nocardiosis in Iran. The present study 
thus aimed to evaluate the pulmonary nocardiosis 
in suspected tuberculosis patients using systematic 
review and meta-analysis of cross-sectional studies. 
 
METHODS AND MATERIALS 
 
Search strategy: We conducted a systematic 
search for cross-sectional studies focused on the 
pulmonary nocardiosis among patients with 
pulmonary tuberculosis based on the Preferred 
Reporting Items for Systematic reviews and Meta-
analysis (PRISMA) published from January 2001 
to October 2019. A systematic literature search was 
conducted in MEDLINE/PubMed, Web of Science, 
Scopus, Cochrane Library, Google Scholar, and 
Science Direct databases. Medical subject headings 
(MeSH) and text words were searched within titles, 
abstracts, and keywords. The search strategy was 
as follows: “pulmonary nocardiosis”, 
“nocardiosis”, OR “nocardial infection”, 
“pulmonary nocardia infections/agents”, AND 
“pulmonary tuberculosis”, OR “pulmonary TB”, 
AND “Iran”. We included articles published in 
English and Persian languages. Two reviewers, 
A.K and AN, conducted the literature search. The 
reference sections of retrieved studies were 
checked to find further relevant studies.  
Inclusion and exclusion criteria: All parts of the 
studies were read to check them against the 
eligibility criteria. The inclusion criteria were: a) 
cross-sectional design, and b) assessing infection of 
Nocardia and pulmonary TB. Studies published 
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before 2001, case reports, abstracts, editorials, 
literatures reporting inadequate data, case series, 
congress articles, meeting reports, letters to editors, 
articles published in languages other than English 
and Persian, duplicate publications, all review 
forms were excluded. This peer-review process 
was performed independently by two reviewers 
(AK, AN). Finally, discrepancies between two 
reviewers were resolved by involving a third 
reviewer. 
 
Quality evaluation: In the assessment process of 
the qualities of studies, an appraisal tool for Cross-
Sectional Studies (AXIS) was used.   According to 
its guidelines, twenty items were considered for 
each study.  If the associated data was mentioned, a 
question was scored ‘yes’. In case of any doubt or 
unclear data, a question was marked ‘no’ or ‘can’t 
tell’. A scoring system was used. Based on the 
number of questions scored ‘yes’, the quality of 
studies was classified as ‘strong’, ‘intermediate’, or 
‘weak’ (23). Studies with weak quality were 
removed from the present review. 
 
Data extraction: In the designed forms, data such 
as the following were listed: author’s name, year of 
publication, location (province or city), sample size 
(TB+), event (pulmonary nocardiosis), and sample 
type. 
 
Statistical meta-analysis: Comprehensive  Meta-
Analysis software (Version 3.3.070) was used for 
meta-analysis. The statistical significance level was 
considered as P < 0.05. The fixed-effects model 
was used to calculate total effects. Cochran’s Q and 
I square (I2) tests were used for assessing sources 
of heterogeneity among studies. Publication bias 
was checked by Egger’s regression asymmetry test.  
 
RESULTS 
 
Study selection: In total, 234 relevant articles were 
recognized via the initial literature search 
(Figure1). About 111 records were excluded due to 
duplications. Fifty-six studies were removed due to 
the irrelevant titles. Then, abstracts 67 remained 
records were screened. It resulted in the exclusion 
of 13 irrelevant topics. After that, 37 records were 
excluded because they were case reports. 
Seventeen full-text literatures were assessed 
against eligibility criteria which led to the 
exclusion of 13 other studies that did not satisfy the 
criteria. Finally, 4 studies were included in the 
current review (Meta-analysis). 
Characteristics of the included studies: All the 4 
included cross-sectional studies that had been 
published between January 2001 to October 2019. 
Overall, 476 TB suspected patients were enrolled 
as total sample size. The pulmonary nocardiosis 
prevalence varied from 1.7% to 6.7%. Phenotypic 
methods (i.e. AFB analysis-Direct Microscopy-
Culture, Gram staining, and Ziehl-Neelsen 
technique) and biochemical tests had been used to 
detect candidiasis in all the studies. The detailed 
characteristics of the included studies are listed in 
Table 1. 
 
Table 1: Characteristics of selected studies in this systematic review and meta-analysis  
Study Time of 
study 
Publication 
(years) 
Sample 
size 
(suspected 
TB) 
Location Samples 
type 
Pulmonary 
nocardiosis   
 (N, %) 
 
Zaker 
Bostanabad(37) 
2011-13 2013 90 Khuzestan-
Tehran 
BAL-
Sputum, 
Wounds 
6(6.7)  
Ekrami(28) 2011-12 2014 32 Ahvaz Sputum 2(6.3)  
Family(38) 2011-12 2014 116 Tehran BAL 7(6)  
Fatahi(39)  2011-13 2015 238 Tehran  Sputum 4(1.7)  
Neg: Negative 
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Figure 1: Flow diagram of inclusion process of selected studies
Overall effects: The combined prevalence of 
nocardiosis among patients with suspected 
pulmonary tuberculosis in Iran was 4.8% (95% CI: 
3-7.3, Q=5.8, Z=12.7) (Table 2, Figure 2).  No 
publication bias was detected by the Funnel plot 
(Figure 3), although Egger’s regression test showed 
the bias (p=0.77). In addition, no heterogeneity was 
observed between studies; I2 was 48.3. Among 4 
studies, only 2 reported the Nocardai spp., as Zaker 
Bostanabad et al. reported 4 and 2 isolates of N. 
asteroides and N. wallacei, respectively. Also, 
Family et al. reported 6 and 1 isolates of N. 
cyriacigeorgica and N. otitidiscaviarum, 
respectively.  
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Table 2:  The overall effect of the prevalence of pulmonary nocardiasis among patients with suspected 
pulmonary tuberculosis. 
 
 
Overall 
effects 
Number 
of studies 
Heterogeneity test Egger’s test Random model 
Prevalence 
(95% CI) (%) 
Z P Q P I2 T  P 
nocardiosis  4 4.8%(3-7.3) 12.7 0.121 5.8 0.77 48.3 0.32 0.00 
 
Figure 2: The Forest plot of the meta-analysis of the prevalence of pulmonary nocardiasis among patients 
with suspected pulmonary tuberculosis  
 
 
Figure 3: Funnel plot of meta-analysis on the prevalence of pulmonary nocardiasis in patients with 
suspected pulmonary tuberculosis 
 
DISCUSSION  
 
In the present systematic review and meta-analysis, 
we included the studies which reported Nocardia 
spp. in patient groups who suffered from TB or 
patients suspected TB. We observed Nocardia in 
both groups. The noticeable point is that in 
suspected TB patients with negativity in all TB 
diagnosis laboratory tests, cases of nocardiosis 
were confirmed. In some cases, they may be 
mistaken for tuberculosis due to the lack of specific 
symptoms (24). Therefore, patients with clinical 
symptoms of tuberculosis that do not recover 
Mycobacterium tuberculosis may have other 
pathogens such as fungi and Nocardia species (25). 
Similarly, several patients identified as smear-
negative for pulmonary Tuberculosis will have 
nocardiosis as reported by Rasheed et.al (26).  
Molecular techniques are needed to identify 
this microorganism due to the similarities between 
nocardiosis and Tuberculosis manifestations (27). 
In the present review, it was found that, in one 
study conducted by Ekrami and et al (28), the 
samples belonged to admitted HIV-infected 
patients. The samples were studied using 
phenotypic (Gram and Ziehl-Nelsen staining, 
culture) and molecular methods (PCR). They 
reported that two HIV infected patients were 
positive for Nocardia spp. when PCR used for 
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diagnosis of pulmonary tuberculosis. In accordance 
with their results, Alnaum et al. reported the 
prevalence of 3-4% of pulmonary nocardiosis in 
HIV-infected patients with pulmonary tuberculosis 
(29). Of course, others reported more co-infection 
of Nocardia with pulmonary tuberculosis (30). 
In patients who do not respond to the usual 
anti-bacterial or anti-TB treatment, there will be a 
possibility of nocardiosis (29,31). Accurate 
identification of Nocardia species has become 
increasingly important because optimal therapeutic 
strategies depend on rapid and accurate 
identification of Nocardia spp. Molecular methods 
for identification (such as PCR, RFLP, and 
16SrRNA sequencing), are time-saving than 
routine phenotypic methods (9). 
Our findings reported the combined 
prevalence of nocardiosis among patients with 
suspected pulmonary tuberculosis 4.8%. 
Prevalence of pulmonary nocardiosis varied from 
1.7% to 6.7%. 
This difference in the prevalence of Nocardia 
in studies included in the current review from Iran 
possibly can be attributed to geographical location, 
the methods used for detection (phenotypic and 
molecular methods), and also patient groups (-
patients suspected of TB or HIV patients who 
suffered from TB) (32). Nocardiosis is a global 
concern, as Nocardia infections are not rare with 
an annual prevalence rate between 500-1,000 cases, 
85% of which are pulmonary or systemic infections 
(33). 
Also, the studies included in this review reported 
the N. cyriacigeorgica and N. asteroides as the 
prevalent isolates, respectively. Inconsistent with 
our findings, N. asteroids is the most causative 
agent in most pulmonary nocardiosis cases in the 
USA and Europian countries (33).  
The outcomes of pulmonary nocardiosis are 
very bad. The mortality rate resulted from 
pulmonary nocardiosis is between 30–35% and 
increased to 64% in the disseminated form (13,34-
36). 
We understood the importance and outcome of 
pulmonary nocardiosis in suspected pulmonary TB 
patients and its misdiagnosis with TB since the 
manifestations are similar. Thus, it is important to 
establish molecular techniques with high sensitivity 
and specificity alongside conventional phenotypic 
methods to improve the speed of diagnosis of 
nocardiosis.   
In the present systematic review and meta-
analysis, we included studies that reported 
Nocardia spp. in patient groups who suffered from 
TB or patients suspected TB. We observed in both 
groups that Nocardia was seen. The noticeable 
point was that in patients suspected of TB, where 
all tests used for detection of TB, were negative 
while cases of nocardiosis were confirmed which is 
considered. Therefore, implanting molecular 
methods alongside conventional phenotypic 
methods to improve the speed of diagnosis of 
nocardiosis is necessary.   
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